(Press-News.org) UNIVERSITY PARK, Pa. — Viruses are typically described as tiny, perfectly geometric shells that pack genetic material with mathematical precision, but new research led by scientists at Penn State reveals a deliberate imbalance in their shape that helps them infect their hosts.
The finding, the researchers say, not only illuminates a fundamental viral strategy but also opens doors for antiviral drug design and molecular delivery technologies critical for vaccines, cancer therapies, medication development and gene editing.
The team published their findings today (Dec. 12) in the journal Science Advances and have filed a patent application related to the discovery.
“A virus lacks sensory organs, so it uses chemical cues to determine how it replicates its genetic material into new viral packages or assemblies with precise polarity,” said Ganesh Anand, associate professor of chemistry, biochemistry and molecular biology at Penn State and lead author on the study. “This polarity guides the RNA, its genetic material that allows the virus infection to spread, and our research shows that asymmetry is what gives the virus this essential polarity. Viruses build these subtle imperfections into their shells to control how and where their genetic material is packaged and poised to exit during an infection.”
The researchers used advanced imaging techniques, conducted at Penn State’s publicly funded Core Facilities, to study the architecture of the Turnip Crinkle Virus (TCV). This plant pathogen has an icosahedral — or 20-sided — shell that is the same structure as many human pathogens, such as enteroviruses, noroviruses, poliovirus, hepatitis B virus and the virus that causes chickenpox.
They found that icosahedral viruses use a single chemical bond to tip the scales inside their protein shells to guide release of RNA and infect their hosts. This bond, called an isopeptide link, connects two structural proteins that contribute to the virus’s shell and creates a subtle asymmetry that clusters the virus’s RNA on one side of the particle, ensuring the genetic material exits in one direction when infecting a host.
It can be compared to a trick or “loaded” die, Anand said, referring to dice that are secretly weighted on one side and used to cheat in games.
“When the virus enters a cell and begins to break apart, this ‘loaded die’ design ensures the genetic material bursts out through a specific exit point — fast and in the right direction — so it can immediately hijack the host’s machinery to make more virus,” Anand said.
One tiny isopeptide link is responsible for this “loaded die” effect, he explained. It acts like a kind of molecular hinge or strap, anchoring RNA to one half of the particle and putting it slightly off balance to create a spring-loaded genome. When the virus enters its host’s cells and starts to break apart, the RNA is launched out through a specific exit point.
“The RNA doesn’t just float around,” Anand said. “It’s positioned right where the plant’s ribosomes, its protein-makers, can grab it. This lets the virus start making its own proteins immediately, before the plant can mount a defense.”
The team captured this previously unseen moment, a partially expanded virus poised for release, using two advanced imaging techniques that can monitor microscale changes within cells: cryo-electron microscopy and hydrogen-deuterium exchange mass spectrometry.
“We were able see the polarity of the particle and it appeared to be positioned somewhere very close to where the RNA looked like it was wanting to get out,” said Varun Venkatakrishnan, a Penn State doctoral student and co-author on the paper who led the cryo-electron microscopy aspects of the work. “This ‘loaded die’ mechanism that we discovered isn’t just a plant virus trick. It could be a universal strategy for how these types of viruses package themselves.”
For human viruses, like those that cause colds or even those that can lead to less common diseases, RNA release is a critical step. Many viruses, like poliovirus or enteroviruses, have icosahedral shells and need to eject their RNA at the right time and place inside a host cell. If they could bias that process, like Turnip Crinkle Virus does, they’d gain speed and precision needed to evade immune defenses, Venkatakrishnan said.
Finding a way to disrupt the process of RNA release by targeting asymmetric features such as the isopeptide link in Turnip Crinkle Virus could lead to new antiviral therapies or better RNA therapeutics, drugs that prevent infection and autoimmune disorders, explained Sean Braet, a postdoctoral researcher at Penn State and co-author on the paper.
“This could mean designing vaccines that release RNA exactly where it’s needed, near protein-making machinery, to reduce degradation and boost effectiveness of the vaccine,” Braet said. “There is a specific feature on the RNA that can help to direct this process, and now, we’re in the process of figuring out if we can use this naturally occurring phenomena to the advantage of cost-efficiently amplifying expression of therapeutic RNAs in plant virus vectors.”
Antivirals, drugs specifically designed to treat viral infections such as oseltamivir for influenza, could be designed to bind these asymmetrical sites, he added, destabilizing the shape of the shell and preventing the virus from maintaining its spring-loaded state. This would make it harder for the virus to replicate and evolve resistance inside the host.
"All of this research is very cutting edge and is going on right now,” Anand said. “We have some promising leads.”
Other Penn State co-authors are Molly Clawson, an undergraduate student in the Schreyer Honors College majoring in chemistry, and Tatiana Laremore, director of the University's Proteomics and Mass Spectrometry Core Facility. Ranita Ramesh and Sek-Man Wong of the National University of Singapore also contributed to the work.
The National Institute of General Medical Sciences of the U.S. National Institutes of Health funded this work, along with Penn State’s Huck Institutes of the Life Sciences through the Patricia and Stephen Benkovic Research Initiative and the Stephen and Patricia Benkovic Summer Research Award in Chemistry.
END
Unique bond identified as key to viral infection speed
Discovery opens doors for antiviral drug design and molecular delivery technologies critical for vaccines, cancer therapies, medication development and gene editing
2025-12-12
ELSE PRESS RELEASES FROM THIS DATE:
Indoor tanning makes youthful skin much older on a genetic level
2025-12-12
Tanning bed users are known to have a higher risk of skin cancer, but for the first time researchers have found that young indoor tanners undergo genetic changes that can lead to more mutations in their skin cells than people twice their age.
The study, which was led by UC San Francisco and Northwestern University, appears Dec. 12 in Science Advances.
“We found that tanning bed users in their 30s and 40s had even more mutations than people in the general population who were in their 70s and ...
Mouse model sheds new light on the causes and potential solutions to human GI problems linked to muscular dystrophy
2025-12-12
Myotonic dystrophy type 1 (DM1) is the most common form of adult-onset muscular dystrophy, affecting about 1 in 8,000 people. While it is well known for causing muscle weakness and stiffness, DM1 also affects other organs, including the brain, heart and gastrointestinal (GI) tract. Although around 80% of people with DM1 experience GI problems that greatly reduce their quality of life, including difficulty swallowing, delayed stomach emptying, constipation and severe conditions like intestinal obstruction, the underlying causes remain understudied.
To shed light onto the causes and potential solutions to ...
The Journal of Nuclear Medicine ahead-of-print tip sheet: December 12, 2025
2025-12-12
Reston, VA (December 12, 2025)—New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the Society of Nuclear Medicine and Molecular Imaging, an international scientific and medical organization dedicated to advancing nuclear medicine, molecular imaging, and theranostics—precision medicine that allows diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes.
Summaries of the newly published research articles are provided below.
Tracking Kidney Cancer Spread with a New Targeted Imaging Tool
This study explored whether two biomarkers—CD70 ...
Smarter tools for peering into the microscopic world
2025-12-12
The microscopic organisms that fill our bodies, soils, oceans and atmosphere play essential roles in human health and the planet’s ecosystems. Yet even with modern DNA sequencing, figuring out what these microbes are and how they are related to one another remains extremely difficult.
In a pair of new studies, researchers at Arizona State University introduce powerful tools that make this work easier, more accurate and far more scalable. One tool improves how scientists build microbial family trees. The other provides a software foundation used worldwide to analyze ...
Applications open for funding to conduct research in the Kinsey Institute archives
2025-12-12
The Kinsey Institute invites applications for two competitive research awards that provide in-person access to the Institute’s internationally renowned Library & Special Collections at Indiana University Bloomington. These awards support original scholarship drawing on one of the world’s most significant archives on sexuality, relationships, gender, and human behavior—spanning manuscripts, publications, fine art, photography, ephemera, and scientific data across disciplines including biology, medicine, psychology, anthropology, ...
Global measure underestimates the severity of food insecurity
2025-12-12
(Santa Barbara, Calif.) — Before you can address a problem, you need to understand its scope. That’s why the United Nations developed the Integrated Food Security Phase Classification System. Aid organizations rely on analyses from this global partnership, which monitors and classifies the severity of food insecurity to help target assistance where and when it is most needed.
These analyses are multifaceted and complex — often taking place in regions where data is scarce and conditions are deteriorating — and stakeholders tend to assume ...
Child survivors of critical illness are missing out on timely follow up care
2025-12-12
When the unthinkable happens and a child is left critically ill or injured, the miracle workers in pediatric intensive care units around the country work tirelessly to save their lives.
Yet, after discharge from the hospital, many of these children could be missing out on vital follow up care, finds a study from Michigan Medicine.
“There aren't specific guidelines in terms of whether or when a child should follow up with their primary care physician or pediatrician after a stay in the PICU,” ...
Risk-based vs annual breast cancer screening / the WISDOM randomized clinical trial
2025-12-12
About The Study: In a randomized clinical trial, researchers found risk-based breast cancer screening was as safe as annual screening for detecting advanced cancers but did not reduce breast biopsy rates. Corresponding author Laura J. Esserman, MD, MBA, of the University of California, San Francisco, will present the study at the San Antonio Breast Cancer Symposium.
Corresponding Author: To interview Dr. Esserman, contact UCSF Senior Public Information Representative Elizabeth Fernandez by ...
University of Toronto launches Electric Vehicle Innovation Ontario to accelerate advanced EV technologies and build Canada’s innovation advantage
2025-12-12
Toronto, Ontario - The University of Toronto today announced the launch of Electric Vehicle Innovation Ontario (EVIO), a new industry–academic partnership that will accelerate the development and commercialization of next-generation electric vehicle (EV) and mobility technologies.
Led by the University of Toronto, in collaboration with seven other southern Ontario universities, EVIO will embed 37 highly skilled graduate researchers directly inside 20 Ontario EV and mobility companies. The researchers will work on real-world challenges in battery chemistry, charging reliability, power electronics, mobility software, cold-weather ...
Early relapse predicts poor outcomes in aggressive blood cancer
2025-12-12
Mature nodal T-cell lymphoma is a type of rare and aggressive blood cancer. Limited data make it difficult to identify high-risk patients or tailor treatment strategies, so most patients receive similar care despite differences in disease characteristics and outcomes. A new study led by investigators from PETAL Consortium at the Mass General Brigham Cancer Institute found that among patients who achieved a complete remission after initial chemotherapy treatment, survival was worse for those whose disease relapsed within 12 months of initial treatment, suggesting that alternative strategies are needed to benefit these patients. The results are published in Blood.
“The study suggests ...
LAST 30 PRESS RELEASES:
Adding antibody treatment to chemo boosts outcomes for children with rare cancer
Germline pathogenic variants among women without a history of breast cancer
Tanning beds triple melanoma risk, potentially causing broad DNA damage
Unique bond identified as key to viral infection speed
Indoor tanning makes youthful skin much older on a genetic level
Mouse model sheds new light on the causes and potential solutions to human GI problems linked to muscular dystrophy
The Journal of Nuclear Medicine ahead-of-print tip sheet: December 12, 2025
Smarter tools for peering into the microscopic world
Applications open for funding to conduct research in the Kinsey Institute archives
Global measure underestimates the severity of food insecurity
Child survivors of critical illness are missing out on timely follow up care
Risk-based vs annual breast cancer screening / the WISDOM randomized clinical trial
University of Toronto launches Electric Vehicle Innovation Ontario to accelerate advanced EV technologies and build Canada’s innovation advantage
Early relapse predicts poor outcomes in aggressive blood cancer
American College of Lifestyle Medicine applauds two CMS models aligned with lifestyle medicine practice and reimbursement
Clinical trial finds cannabis use not a barrier to quitting nicotine vaping
Supplemental nutrition assistance program policies and food insecurity
Switching immune cells to “night mode” could limit damage after a heart attack, study suggests
URI-based Global RIghts Project report spotlights continued troubling trends in worldwide inhumane treatment
Neutrophils are less aggressive at night, explaining why nighttime heart attacks cause less damage than daytime events
Menopausal hormone therapy may not pose breast cancer risk for women with BRCA mutations
Mobile health tool may improve quality of life for adolescent and young adult breast cancer survivors
Acupuncture may help improve perceived breast cancer-related cognitive difficulties over usual care
Nerve block may reduce opioid use in infants undergoing cleft palate surgery
CRISPR primes goldenberry for fruit bowl fame
Mass General Brigham announces new AI company to accelerate clinical trial screening and patient recruitment
Fat tissue around the heart may contribute to greater heart injury after a heart attack
Jeonbuk National University researcher proposes a proposing a two-stage decision-making framework of lithium governance in Latin America
Chromatin accessibility maps reveal how stem cells drive myelodysplastic progression
Cartilaginous cells regulate growth and blood vessel formation in bones
[Press-News.org] Unique bond identified as key to viral infection speedDiscovery opens doors for antiviral drug design and molecular delivery technologies critical for vaccines, cancer therapies, medication development and gene editing